Type 2 Diabetes Mellitus Completed Phase 4 Trials for Vildagliptin (DB04876)

Also known as: Diabetes Mellitus Non-insulin-dependent / Type-2 Diabetes Mellitus / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus Type-2 / Type 2 Diabetes (T2DM) / Diabetes, Type 2 / Diabetes Mellitus, Type 2 (T2DM) / Diabetes Mellitus,Type 2 / Diabetes Type II / Type-II Diabetes Mellitus / Diabetes Mellitus 2 Type / T2DM / Diabetes Mellitus Type II / Type II Diabetes / Diabetes Mellitus, Type 2 / Type 2 Diabetes Mellitus (T2DM) / Diabetes Type Two / Diabetes Mellitus - Type 2 / Diabetes, Type II / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus. Type 2 / Diabetes Type 2 / Type 2 Diabetes Mellitus (T2D) / Type 2 Diabetes (T2D) / Type II; Diabetes / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / NIDDM / Type-2 Diabetes / Type 2 Diabetes Mellitus(T2DM) / Type 2 Diabetes / Type 2-diabetes / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Mellitus Type 2 / Type Two Diabetes Mellitus / T2DM (Type 2 Diabetes Mellitus) / Type-2-diabetes Mellitus / Diabetes mellitus -adult onset / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02475070Vildagliptin Versus Dapagliflozin on GlucagonBasic Science
NCT01882907Safety and Efficacy Study to Compare Vildagliptin to Pioglitazone as Adding on Metformin in Type 2 DiabetesTreatment
NCT02089438DPP-4 Inhibition, Incretins and Islet FunctionBasic Science
NCT01518101Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both MedicationsTreatment
NCT01309698Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 DiabetesBasic Science
NCT01541956Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION)Treatment
NCT01757587Galvus (Vildagliptin) vs Placebo in Combination With Metformin and InsulinTreatment
NCT02007278Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and GlimepirideTreatment
NCT01528254VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes MellitusTreatment
NCT02853630A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes MellitusTreatment
NCT01404676The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 DiabetesTreatment
NCT02832999Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 DiabetesTreatment
NCT01196546Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM)Treatment
NCT01238978Phase 4 Study in the Elderly Patients With T2DMTreatment
NCT01426802Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With MetforminTreatment
NCT00975065Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes MellitusTreatment
NCT01193296Glycemic Holter Study (Continuous Glucose Monitoring) -Treatment
NCT01356381Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 DiabetesTreatment
NCT01604213Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery DiseaseTreatment
NCT01649466Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients.Treatment
NCT01679899Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic VariabilityTreatment
NCT01758380Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During RamadanTreatment
NCT02145611Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and HypertensionTreatment
NCT02002221Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM PatientsTreatment
NCT01686932Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart FunctionTreatment
NCT01398592Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering EfficacyTreatment
NCT01766778Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by MetforminTreatment
NCT03178591Effects of DPP4 Inhibitor Versus SGLT2 InhibitorTreatment
NCT01582243Safety and Efficacy of Vildagliptin Plus Metformin (SPC) Treatment in Type 2 Diabetes Mellitus PatientsTreatment
NCT00894868Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart FailureTreatment